Agios Pharmaceuticals | Egenkapital Og Reserver

Equity Capital And Reserves Endring Dato
AbbVie USD 8.05B 4.05B 2024-03
Agios Pharmaceuticals USD 743.92M 67.1M 2024-03
Alnylam Pharmaceuticals USD -219272000 1.37M 2024-03
Amgen USD 5.02B 1.21B 2024-03
Arrowhead Research USD 495.4M 335M 2024-03
Astellas Pharma JPY 1.5T 136.09B 2023-12
AstraZeneca USD 37.5B 1.64B 2024-03
Bayer EUR 35.76B 2.84B 2024-03
Biogen USD 15.21B 413.6M 2024-03
BioMarin Pharmaceutical USD 5.07B 122.27M 2024-03
Bristol-Myers Squibb USD 16.55B 12.45B 2024-03
Daiichi Sankyo JPY 1.59T 7.66B 2023-12
Eli Lilly USD 12.9B 1.68B 2024-03
Exelixis USD 2.13B 219.61M 2024-03
Gilead Sciences USD 17.46B 5.29B 2024-03
GlaxoSmithKline GBP 13.23B 118M 2024-03
Incyte USD 5.39B 204.43M 2024-03
Ionis Pharmaceuticals USD 296.52M 90.17M 2024-03
Merck USD 40.42B 822M 2024-03
Moderna USD 12.82B 1.04B 2024-03
Novartis USD 39.76B 6.91B 2024-03
Novartis USD 39.76B 6.91B 2024-03
Pfizer USD 92.56B 4.38B 2024-03
Regeneron Pharmaceuticals USD 26.99B 1.02B 2024-03
Roche Holding CHF 29.32B 2.8B 2023-12
Sarepta Therapeutics USD 961.19M 196.83M 2024-03
Vertex Pharmaceuticals USD 18.55B 2.03B 2024-03



Agios Pharmaceuticals Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.